Design and Synthesis of Cytotoxic Compounds by Targeting Cancer Metabolism
| dc.contributor.author | Hossain, Mohammad | |
| dc.date.accessioned | 2026-10-28T17:35:47Z | |
| dc.date.available | 2026-10-28T17:35:47Z | |
| dc.date.issued | 2026-10-26 | |
| dc.description.abstract | Apart from the well-known properties of malignant cells such as abnormal proliferation, deregulation of apoptosis, and cell cycle, it has now been well established that cancer cells use an altered metabolism compared to normal cells. In fact, cancer cells undergo metabolic re-programming to meet increased energetic and anabolic needs, including those for ATP, reduced coenzymes (e.g., NADPH), lipids, proteins, and nucleotides. Therefore, therapies targeting the metabolic differences between cancers and normal cells have long been a principal strategy for developing novel anticancer drugs for cancer treatment. In this presentation, the synthesis and anticancer properties of three series of novel anticancer compounds will be discussed, which have been designed based on the metabolic differences between cancers and normal cells. | |
| dc.identifier.uri | https://hdl.handle.net/2022/38623 | |
| dc.language.iso | en_US | |
| dc.rights | This work may be protected by copyright unless otherwise stated. | |
| dc.subject | Cancer metabolism | |
| dc.subject | Cytotoxic compounds | |
| dc.subject | Anticancer drug development | |
| dc.subject | Medicinal chemistry | |
| dc.subject | Chemical synthesis | |
| dc.subject | hiol alkylation | |
| dc.subject | Apoptosis | |
| dc.subject | Tumor selectivity | |
| dc.title | Design and Synthesis of Cytotoxic Compounds by Targeting Cancer Metabolism | |
| dc.type | Presentation |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Presentation_Hossain_2026.pdf
- Size:
- 3.1 MB
- Format:
- Adobe Portable Document Format
Collections
Can’t use the file because of accessibility barriers? Contact us